Most Recent
Union accuses McDonald’s of unpaid rest break ‘conspiracy’
McDonald’s Australia has been joined as a second respondent in a union-led lawsuit that accuses the fast food giant of “conspiring to deliberately deny workers their breaks”.
Romeo’s settles two underpayments class actions
Supermarket chain Romeo's has reached a settlement in two class actions alleging staff were underpaid, but details of the agreements are scant.
Judge questions why fees, commission missing from Crown settlement notice
A judge has directed that the legal fees and funding commission sought to be deducted from a $125 million class action settlement with Crown Resorts be included in a proposed notice to shareholders, after learning that group members were forced to click through to Maurice Blackburn's website to find the "critical" figures.
Melissa Caddick’s company wound up, with $23.5M owing to investors
ASIC has won its bid to wind up accused Sydney fraudster Melissa Caddick's company and appoint final receivers to realise her assets, paving the way for some repayment to the dozens of family and friends who invested with Caddick and are still owed $23.5 million.
Monsanto may face claim for exemplary damages in Roundup class action
A class action on behalf of people who claim they developed non-Hodgkin lymphoma after using Monsanto's Roundup weed killer will argue the agrochemical giant should be hit with exemplary damages for its negligence in selling the herbicide, which the company allegedly knew caused cancer.
Union takes legal action against CBA over ‘draconian’ salary secrecy clause
The Finance Sector Union has launched legal proceedings in the Fair Work Commission against the Commonwealth Bank for allegedly sacking an employee who breached a “draconian” salary secrecy clause.
Celgene sues to protect patents for blockbuster cancer drug Revlimid
Bristol-Myers Squib unit Celgene Corporation has sued Indian generics giant Dr Reddy’s Laboratories for allegedly threatening to infringe eight patents for its blockbuster cancer drug Revlimid, which raked in US$12 billion for the US-based company in revenue last year.
Nuix hit with shareholder class action over $1.8B IPO
Embattled technology company Nuix has been hit with a shareholder class action over its $1.8 billion December float on the ASX.
Banksia class action barristers declare bankruptcy after $21.7M judgment
Two former barristers ordered to pay at least $21.7 million in damages and costs for their role in a fraudulent scheme to pocket a windfall from the Banksia Securities class action have filed for bankruptcy.
Full Court shoots down Aristocrat’s patents for popular poker machine
IP Australia has won its appeal of a judge’s decision to allow four Aristocrat patents for its popular Lightning Link electronic poker machine to proceed to grant, with the Full Court finding the invention merely implemented an abstract idea on a computer and was not patentable.